---
figid: PMC6520835__cancers-11-00538-g003
figtitle: Therapeutic targeting of oncogenic HH/GLI signaling in cancer cells resistant
  to SMOi
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6520835
filename: cancers-11-00538-g003.jpg
figlink: /pmc/articles/PMC6520835/figure/cancers-11-00538-f003/
number: F3
caption: 'Therapeutic targeting of oncogenic HH/GLI signaling in cancer cells resistant
  to SMOi. Summary of targeting options to block pathways and signaling mechanisms
  accounting for SMO-independent GLI activation and SMOi resistance development. GF:
  Growth factor.'
papertitle: Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy.
reftext: Elisabeth Peer, et al. Cancers (Basel). 2019 Apr;11(4):538.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9657141
figid_alias: PMC6520835__F3
figtype: Figure
redirect_from: /figures/PMC6520835__F3
ndex: 366860ea-ded2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6520835__cancers-11-00538-g003.html
  '@type': Dataset
  description: 'Therapeutic targeting of oncogenic HH/GLI signaling in cancer cells
    resistant to SMOi. Summary of targeting options to block pathways and signaling
    mechanisms accounting for SMO-independent GLI activation and SMOi resistance development.
    GF: Growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Su(fu)
  - Gli
  - ci
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - Egfr
  - Jag
  - jar
  - Dl
  - .na.character
  - Tapdelta
  - deltaTry
  - smo
  - sm
  - arr
  - hh
  - Tie
  - Ras85D
  - InR
  - hop
  - bsk
  - fz
  - ptc
  - ato
  - ras
  - Ras64B
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - CkIalpha
  - Akt
  - Raf
  - Axn
  - Erk7
  - rl
  - S6k
  - Mtor
  - Tor
  - Apc
  - Apc2
  - Fs(3)Apc
  - HDAC4
  - HDAC6
  - HDAC1
  - HDAC3
  - sgg
  - Dsor1
  - Mtk
  - CkIIbeta
  - CkIIbeta2
  - CkIIalpha
  - aPKC
  - Jra
  - 'On'
  - fs(1)h
  - gish
  - SUFU
  - GLI1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - EGF
  - PSMB6
  - YY1
  - DLL1
  - IL6
  - IL6ST
  - NM
  - LRPPRC
  - SMO
  - SMOX
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - PTCH1
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CSNK1A1
  - DYRK1B
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AXIN1
  - AXIN2
  - EPHB2
  - MAPK1
  - MAPK3
  - RPS6KB1
  - MTOR
  - APC
  - PROC
  - HDAC9
  - HDAC2
  - HDAC8
  - HDAC5
  - HDAC7
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - GSK3A
  - GSK3B
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CSNK2A1
  - CSNK2A2
  - CSNK2B
  - HES1
  - GATD3
  - GPR161
  - STAT3
  - JUN
  - JUNB
  - JUND
  - BRD4
  - KRT1
  - CSNK1A1L
  - LEQ-506
  - Itraconazole
  - Gefitinib
  - Erlotinib
  - Afatinib
  - Br
  - ATO
  - RO4929097
  - Pyrvinium
  - Mocetinostat
  - CRTO329868
  - Trametinib
  - Domatinostat
  - Cobimetinib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
